Announcements Trials
Browse Landscape

Phase

Phase 4 3Phase 3 2Phase NA 1Phase 2 1

Status

Terminated 3

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Sarcoma 1

Conditions

Pain, Intractable 1Pain 1Neoplasms 1Leiomyoma 1Bone Neoplasms 1

Interventions

Saline Solution 10Docetaxel 10Bevacizumab 9nilotinib 8enzalutamide 8Paclitaxel 8Letrozole 8Fentanyl 8Everolimus 8Cyclophosphamide 8Carboplatin 8Bupivacaine 8Lidocaine 7Sodium Chloride 6Oxycodone 6Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 6Erlotinib Hydrochloride 6Dexamethasone 6Capecitabine 6Trastuzumab 5Tobacco Use Cessation Devices 5Surveys and Questionnaires 5Nivolumab 5Hydromorphone 5Adalimumab 5fludarabine 4Zoledronic Acid 4Tranexamic Acid 4Tacrolimus 4Rocuronium 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 4 × Has results × Pregabalin × Clear all
NCT00380874 2021-02-11

Prevention And Treatment Of Chemotherapy-Induced Peripheral Neuropathy In Subjects With Advanced Colorectal Cancer

Pfizer

Phase 4 Terminated
64 enrolled 10 charts

Pain

NCT00381095 2021-01-20

COPE

Pfizer

Phase 4 Terminated
152 enrolled 14 charts
Sarcoma

Bone Neoplasms, Neoplasms, Pain, Intractable

NCT01555073 2016-07-28

Preemptive Analgesia Following Uterine Artery Embolization

Northwestern University

Phase 4 Terminated
23 enrolled 6 charts

Leiomyoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡